Growth Metrics

Incyte (INCY) Operating Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 530.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -1,211.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 6,993.00
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 2,060.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,060.00
Dec 31, 2025 1,473.00
Sep 30, 2025 1,566.00
Jun 30, 2025 1,571.00
Mar 31, 2025 359.00
Dec 31, 2024 1,275.00
Sep 30, 2024 -1,612.00
Jun 30, 2024 -6,577.00
Mar 31, 2024 -591.00
Dec 31, 2023 -232.00
Sep 30, 2023 2,250.00
Jun 30, 2023 -1,324.00
Mar 31, 2023 11,986.00
Dec 31, 2022 -883.00
Sep 30, 2022 -754.00
Jun 30, 2022 931.00
Mar 31, 2022 102.00
Dec 31, 2021 1,719.00
Sep 30, 2021 2,204.00
Jun 30, 2021 400.00
Mar 31, 2021 3,389.00
Dec 31, 2020 2,043.00
Sep 30, 2020 -308.00
Jun 30, 2020 3,132.00
Mar 31, 2020 -8,211.00
Dec 31, 2019 3,641.00
Sep 30, 2019 1,608.00
Jun 30, 2019 50.00
Mar 31, 2019 120.00
Dec 31, 2018 -1,136.00
Sep 30, 2018 697.00
Jun 30, 2018 2,050.00
Mar 31, 2018 -1,320.00
Dec 31, 2017 2,104.00
Sep 30, 2017 -3,136.00
Jun 30, 2017 2,852.00
Mar 31, 2017 -915.00
Dec 31, 2016 990.00
Sep 30, 2016 2,376.00
Jun 30, 2016 107.00
Mar 31, 2016 1,944.00
Dec 31, 2015 -499.00
Sep 30, 2015 1,671.00
Jun 30, 2015 -2,212.00
Mar 31, 2015 9,014.00
Dec 31, 2014 13,212.00
Sep 30, 2014 28,619.00
Jun 30, 2014 21,827.00
Mar 31, 2014 2,395.00
Dec 31, 2013 -4,984.00
Sep 30, 2013 11,524.00
Jun 30, 2013 -1,030.00
Mar 31, 2013 10,894.00